In addition to being a possible therapeutic target for kidney disease, USAG-1 may also be used as a biomarker of renal prognosis—the expression of USAG-1 in a renal biopsy specimen from a mouse model of CKD is related to the prognosis of renal function [5, 28]. Here, SOSTDC1 is linked to chronic kidney disease.